HK Stock Market Move | HBM HOLDINGS-B(02142) rose over 5% and will co-establish a new generation AI pipeline research and development company, MegaStream, with BaiTu Life Sciences.

HBM HOLDINGS-B (02142) rose by more than 5%, reaching a 5.34% increase at the time of writing, at 10.66 Hong Kong dollars, with a trading volume of 1104.54 million Hong Kong dollars. In recent news, HBM HOLDINGS-B announced that the company will establish a multi-level, long-term comprehensive strategic partnership with BAITU Life Sciences, focusing on AI-driven complex macromolecular drug discovery and development. The aim is to systematically solve key research and development bottlenecks for next-generation innovative therapies and jointly create an AI research and development ecosystem with global leading competitiveness. According to the strategic cooperation framework, the company and BAITU Life Sciences will jointly establish a new generation AI pipeline research and development company, MegaStream TechBio (MegaStream), targeting the global market. MegaStream will integrate "exclusive big data x exclusive big models x large innovative pipeline combinations" and build an AI research and development engine centered on advanced integrated intelligent dry and wet closed-loop experimental discovery platform and personalized, multimodal, and multi-attribute generative big models. MegaStream will focus on major unmet clinical needs such as cardiovascular, kidney, tumor, anti-aging, using First-in-Class (FIC) and Best-in-Class (BIC) assets as the core research and development benchmarks.